Is AnPac Bio-Medical Science (ANPC ) Stock Still a Good Buy After Big Move?

Those looking for some action in the premarket trading period might consider having a look at the AnPac Bio-Medical Science Co Ltd (NASDAQ:ANPC ) stock, which has soared by 30% at the time of writing.

Is AnPac Bio-Medical Science (ANPC ) Stock Still a Good Buy After Big Move?

The company announced this morning that its board of directors voted in favor with regards to the establishment of a joint venture with Dr. Chris Chang Yu, the company’s founder and chairman. The joint venture is going to be established with Dr. Yu and some other people.

Related:  Is Brooklyn ImmunoTherapeutics (BTX) Stock a Good Buy Below $15?

The venture is going to be focused on the development of new technology for cancer treatment and other products. AnPac is going to contribute a total of two patent applications related to cancer treatments to this joint venture. The share of the company in the joint venture is going to be decided after the value of the patent applications is determined by an independent appraisal company. In the meantime, investors could consider tracking the AnPac stock.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.